GILD vs MRNA
Gilead Sciences, Inc. - Common Stock · Moderna, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | GILD | MRNA |
|---|---|---|
| Price | $144.74 | $190.01 |
| Market Cap | $179.47B | $75.86B |
| P/E | 21.09 | — |
| P/B | 15.17 | 11.22 |
| P/S | 6.10 | 39.02 |
| ROE | 71.9% | -41.7% |
| Net Margin | 28.9% | -145.2% |
| Gross Margin | — | — |
| Revenue Growth | 2.4% | -39.9% |
| Dividend Yield | 2.18% | — |
| EPS | $6.86 | -$7.07 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.